Evidence-backed FAQ
What does research show about probiotics taken with antibiotics?
In pooled randomized trials of adults, probiotics taken alongside antibiotics were associated with about a 37% to 38% lower risk of antibiotic-associated diarrhea. The effect varied by strain or species, dose, timing, and baseline risk, and the evidence does not establish one universal regimen.[1], [2]
Important limitations
The evidence was graded moderate quality and was heterogeneous. It applies to adults in the studied settings, does not identify one optimal strain, CFU amount, timing, or duration, and cannot be transferred automatically to fermented foods or unspecified live cultures. It also does not establish safety for immunocompromised or critically ill people.[1], [2], [3]
What the evidence shows
Two 2021 meta-analyses included more than 9,000 adults each. Pooled adverse-event data did not show a statistically significant increase versus placebo, but the findings do not establish safety for immunocompromised or critically ill people.[1], [2]
Two large meta-analyses found a similar pooled effect
One 2021 systematic review pooled 42 randomized trials with 11,305 adults, and another pooled 36 randomized placebo-controlled trials with 9,312 adults.[1], [2]
Both found that probiotics used alongside antibiotics were associated with a relative risk near 0.62 to 0.63 for antibiotic-associated diarrhea, equivalent to about a 37% to 38% lower pooled risk.[1], [2]
The result is not for one universal product
The trials used different probiotic strains, species, combinations, CFU amounts, start times, and durations.[1], [2]
The pooled average therefore supports a category of studied interventions in adults, not interchangeability of every product sold as a probiotic.[1], [2], [3]
Fermented foods are not the same evidence as the studied interventions
The antibiotic-associated-diarrhea evidence comes from defined probiotic interventions used in randomized trials. A fermented food or traditional live culture is not automatically a probiotic merely because it contains microorganisms.[1], [2], [3]
Because the pooled findings depend on the studied strains or defined products, amounts, populations, and settings, those results should not be transferred automatically to yogurt, fermented foods, or an unspecified live-culture product.[1], [2], [3]
Baseline diarrhea risk influenced the finding
In subgroup analysis, significant risk reduction was concentrated in moderate- or high-risk settings and was not observed in studies with low baseline diarrhea risk.[1]
The expected absolute benefit can therefore differ substantially across populations even when the relative pooled result appears favorable.[1], [2]
Dose-response was qualified and product-specific
A higher dose of the same probiotic was more protective than a lower dose in a subgroup analysis.[1], [4]
That does not establish that the highest total CFU count across unrelated strains or products is best. The comparison remained tied to the same probiotic and indication.[1], [3], [4]
Some organism groups contributed more to the signal
The 42-trial review reported that benefit came mainly from lactobacillus and bifidobacteria species.[1]
A broad species-level subgroup still does not erase strain and formulation differences or prove that every related product produces the pooled effect.[1], [3]
Adverse-event data were reassuring in studied adults
The 36-trial analysis found no statistically significant increase in adverse events versus placebo, with a pooled relative risk of 1.00.[2]
That result is bounded to the adult trial populations and does not establish safety for immunocompromised, critically ill, or otherwise medically vulnerable people.[2]
Timing and duration remain undefined
The reviews described early co-administration as favorable, but trials varied and the optimal start time, separation from an antibiotic dose, and total duration were not established.[1], [2]
This evidence should not be converted into medication-timing instructions or used to change, delay, or stop a prescribed antibiotic.[1], [2]
Questions covered by the supporting research
These related questions are addressed in the cited evidence summaries and linked pages.
- How large was the pooled reduction in antibiotic-associated diarrhea?
- Can fermented foods be assumed to provide the same evidence as studied probiotic products?
- Did baseline diarrhea risk change the result?
- Was a higher dose always better?
- Do the trials establish when to take a probiotic relative to an antibiotic?
Read the supporting evidence summaries
The linked research pages provide study populations, formulations, doses, outcomes, and limitations in greater detail.
Related questions
References
- Probiotics for the prevention of antibiotic-associated diarrhoea: a systematic review and meta-analysis.. BMJ open. 2021. Systematic review and meta-analysis View source →
- Probiotics for the Prevention of Antibiotic-associated Diarrhea in Adults: A Meta-Analysis of Randomized Placebo-Controlled Trials.. Journal of clinical gastroenterology. 2021. Systematic review and meta-analysis View source →
- Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nature Reviews Gastroenterology & Hepatology. 2014. Expert consensus statement View source →
- A review of dose-responses of probiotics in human studies.. Beneficial microbes. 2017. Narrative review View source →